Archives
|
Entry
|
Blogger
|
Date
|
Location
|
|
Pulmatrix Scores $30M To Block All Sorts of Bugs That Make People Sick in the Lungs
|
Luke Timmerman |
11/02/09 |
Boston
|
|
AstraZeneca Plans Local Job Cuts, Report Says
|
Ryan McBride |
09/11/09 |
Boston
|
|
Pulmatrix, With One Drug for Multiple Bugs, Aims to Fundamentally Change Flu Treatment
|
Luke Timmerman |
06/09/09 |
Boston
|
|
NKT Therapeutics Aims For Severe Asthma, Targeting Natural Killer T Cells
|
Ryan McBride |
05/18/09 |
Boston
|
|
Altair Therapeutics Changes CEO
|
Juha-Pekka Tikka |
05/14/09 |
San Diego
|
|
Calistoga Raises $30M to Develop Drugs for Cancer, Inflammation
|
Luke Timmerman |
05/05/09 |
Seattle
|
|
Axikin Raises $3M After Spinning Out From Actimis
|
Ryan McBride |
01/22/09 |
San Diego
|
|
KaloBios Gets $12M Genzyme, Baxter
|
Luke Timmerman |
12/22/08 |
Boston
|
|
Oral Pill May Make Tough-to-Deliver RNAi Drugs Go Down Easy, RXi Says
|
Luke Timmerman |
11/13/08 |
Boston
|
|
Calistoga Builds Cancer Drug Strategy, Hires First CEO, Carol Gallagher
|
Luke Timmerman |
10/08/08 |
Seattle
|
|
MPM Capital, World’s Biggest Healthcare VC Fund, Balances Startups With Stocks
|
Luke Timmerman |
10/07/08 |
Boston
|
|
Idera Receives Milestone Payment from Novartis For Asthma and Allergy Collaboration
|
Luke Timmerman |
09/02/08 |
Boston
|
|
Taligen CEO Aims to Develop Drugs For Inflammatory Diseases, Build Company in Cambridge
|
Luke Timmerman |
08/14/08 |
Boston
|
|
Resolvyx Experiment Shows Fish-Oil Derivative Tamps Down Asthma, Inflammation
|
Luke Timmerman |
07/03/08 |
Boston
|
|
Page 1 of
1 |
|
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2009, Xconomy, Inc.
XCONOMY is a registered service mark of Xconomy, Inc.
All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
